375 related articles for article (PubMed ID: 21050171)
1. GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.
Atack JR
Curr Top Med Chem; 2011; 11(9):1203-14. PubMed ID: 21050171
[TBL] [Abstract][Full Text] [Related]
2. GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.
Atack JR
Curr Top Med Chem; 2011; 11(9):1176-202. PubMed ID: 21050172
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist.
Atack JR; Maubach KA; Wafford KA; O'Connor D; Rodrigues AD; Evans DC; Tattersall FD; Chambers MS; MacLeod AM; Eng WS; Ryan C; Hostetler E; Sanabria SM; Gibson RE; Krause S; Burns HD; Hargreaves RJ; Agrawal NG; McKernan RM; Murphy MG; Gingrich K; Dawson GR; Musson DG; Petty KJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):470-84. PubMed ID: 19704033
[TBL] [Abstract][Full Text] [Related]
4. GABA(A) receptor subtype-selective efficacy: TPA023, an alpha2/alpha3 selective non-sedating anxiolytic and alpha5IA, an alpha5 selective cognition enhancer.
Atack JR
CNS Neurosci Ther; 2008; 14(1):25-35. PubMed ID: 18482097
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding site.
Street LJ; Sternfeld F; Jelley RA; Reeve AJ; Carling RW; Moore KW; McKernan RM; Sohal B; Cook S; Pike A; Dawson GR; Bromidge FA; Wafford KA; Seabrook GR; Thompson SA; Marshall G; Pillai GV; Castro JL; Atack JR; MacLeod AM
J Med Chem; 2004 Jul; 47(14):3642-57. PubMed ID: 15214791
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition.
Chambers MS; Atack JR; Broughton HB; Collinson N; Cook S; Dawson GR; Hobbs SC; Marshall G; Maubach KA; Pillai GV; Reeve AJ; MacLeod AM
J Med Chem; 2003 May; 46(11):2227-40. PubMed ID: 12747794
[TBL] [Abstract][Full Text] [Related]
7. An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition.
Dawson GR; Maubach KA; Collinson N; Cobain M; Everitt BJ; MacLeod AM; Choudhury HI; McDonald LM; Pillai G; Rycroft W; Smith AJ; Sternfeld F; Tattersall FD; Wafford KA; Reynolds DS; Seabrook GR; Atack JR
J Pharmacol Exp Ther; 2006 Mar; 316(3):1335-45. PubMed ID: 16326923
[TBL] [Abstract][Full Text] [Related]
8. An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing properties.
Chambers MS; Atack JR; Carling RW; Collinson N; Cook SM; Dawson GR; Ferris P; Hobbs SC; O'connor D; Marshall G; Rycroft W; Macleod AM
J Med Chem; 2004 Nov; 47(24):5829-32. PubMed ID: 15537339
[TBL] [Abstract][Full Text] [Related]
9. GABAA receptor alpha2/alpha3 subtype-selective modulators as potential nonsedating anxiolytics.
Atack JR
Curr Top Behav Neurosci; 2010; 2():331-60. PubMed ID: 21309116
[TBL] [Abstract][Full Text] [Related]
10. RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors.
Ballard TM; Knoflach F; Prinssen E; Borroni E; Vivian JA; Basile J; Gasser R; Moreau JL; Wettstein JG; Buettelmann B; Knust H; Thomas AW; Trube G; Hernandez MC
Psychopharmacology (Berl); 2009 Jan; 202(1-3):207-23. PubMed ID: 18936916
[TBL] [Abstract][Full Text] [Related]
11. Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypes.
Licata SC; Platt DM; Rüedi-Bettschen D; Atack JR; Dawson GR; Van Linn ML; Cook JM; Rowlett JK
Neuropharmacology; 2010 Feb; 58(2):357-64. PubMed ID: 19853619
[TBL] [Abstract][Full Text] [Related]
12. PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats.
Savić MM; Clayton T; Furtmüller R; Gavrilović I; Samardzić J; Savić S; Huck S; Sieghart W; Cook JM
Brain Res; 2008 May; 1208():150-9. PubMed ID: 18394590
[TBL] [Abstract][Full Text] [Related]
13. L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors.
Atack JR; Bayley PJ; Seabrook GR; Wafford KA; McKernan RM; Dawson GR
Neuropharmacology; 2006 Nov; 51(6):1023-9. PubMed ID: 17046030
[TBL] [Abstract][Full Text] [Related]
14. An inverse agonist selective for alpha5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the Morris water maze.
Collinson N; Atack JR; Laughton P; Dawson GR; Stephens DN
Psychopharmacology (Berl); 2006 Nov; 188(4):619-28. PubMed ID: 16633803
[TBL] [Abstract][Full Text] [Related]
15. The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics.
Atack JR
Expert Opin Investig Drugs; 2005 May; 14(5):601-18. PubMed ID: 15926867
[TBL] [Abstract][Full Text] [Related]
16. Alpha1- and alpha2-containing GABAA receptor modulation is not necessary for benzodiazepine-induced hyperphagia.
Morris HV; Nilsson S; Dixon CI; Stephens DN; Clifton PG
Appetite; 2009 Jun; 52(3):675-683. PubMed ID: 19501766
[TBL] [Abstract][Full Text] [Related]
17. Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure.
Fischer BD; Licata SC; Edwankar RV; Wang ZJ; Huang S; He X; Yu J; Zhou H; Johnson EM; Cook JM; Furtmüller R; Ramerstorfer J; Sieghart W; Roth BL; Majumder S; Rowlett JK
Neuropharmacology; 2010 Dec; 59(7-8):612-8. PubMed ID: 20727364
[TBL] [Abstract][Full Text] [Related]
18. Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site.
Atack JR
Curr Drug Targets CNS Neurol Disord; 2003 Aug; 2(4):213-32. PubMed ID: 12871032
[TBL] [Abstract][Full Text] [Related]
19. Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux.
Smith AJ; Alder L; Silk J; Adkins C; Fletcher AE; Scales T; Kerby J; Marshall G; Wafford KA; McKernan RM; Atack JR
Mol Pharmacol; 2001 May; 59(5):1108-18. PubMed ID: 11306694
[TBL] [Abstract][Full Text] [Related]
20. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.
Fradley RL; Guscott MR; Bull S; Hallett DJ; Goodacre SC; Wafford KA; Garrett EM; Newman RJ; O'Meara GF; Whiting PJ; Rosahl TW; Dawson GR; Reynolds DS; Atack JR
J Psychopharmacol; 2007 Jun; 21(4):384-91. PubMed ID: 17092983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
